• Home
  • NEW DAY MEDICINE
  • 3 (31) 2020
  • 142 -3 (31/4) 2020 — Devyatov A.V., Khakimov D.M., — STRATIFICATION OF RISK FACTORS FOR BLEEDING VARICES OF THE ESOPHAGUS AND STOMACH IN PATIENTS WITH DIFFUSE LIVER DISEASE

142 -3 (31/4) 2020 — Devyatov A.V., Khakimov D.M., — STRATIFICATION OF RISK FACTORS FOR BLEEDING VARICES OF THE ESOPHAGUS AND STOMACH IN PATIENTS WITH DIFFUSE LIVER DISEASE

STRATIFICATION OF RISK FACTORS FOR BLEEDING VARICES OF THE ESOPHAGUS AND STOMACH IN PATIENTS WITH DIFFUSE LIVER DISEASE

Devyatov A.V. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Khakimov D.M. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Khodzhimatov G.M. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Akhranova S.T. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Karaboev B.B. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Kasimov N.A. -Republican specialized surgery center named after V.Vakhidov, Tashkent, Uzbekistan, Tashkent Medical Academy, Andijan State Medical Institute.

Resume,

Currently, with a view to the prevention of rebleeding all increasingly widespread endoscopic procedures. However, it remains unclear the question of whether, in a group of patients after endoscopic interventions arises bleeding recurrence. In this regard, we have attempted to stratify the risk factors for bleeding from esophageal varices, and stomach in order to separate the group of patients is a potential risk group. Factor analysis was performed to achieve a sustainable degree of verification of the effect of various risk factors of bleeding from esophageal and gastric varicose veins based on different criteria.

Key words: liver cirrhosis, portal hypertension, risk factors, varicose veins of the esophagus and stomach.

First page

586

Last page

592

For citation: Devyatov A.V., Khakimov D.M., Khodzhimatov G.M., Akhranova S.T., Karaboev B.B., Kasimov N.A., Stratification of risk factors for bleeding varices of the esophagus and stomach in patients with diffuse liver disease//New Day in Medicine 3(31)2020 586-592 https://cutt.ly/ixGzzHi

List of References

  1. Дзидзава И.И. От.даленные результаты хирургической коррек­ции портальной гипертензии и иропюстические факторы вы­живаемости у больных циррозом печени.: Автореф. дис. докт. мед. наук. – Сажт-Петербург. – 2010. – 48 с.
  2. Назыров Ф.Г., Девятов А.В., Бабаджанов А.Х. Сводный анализ результатов и конкурентные перспективы портосистем­ною шунтирования у больных циррозом печени // Анн. хи­рург. гепатологии. 2015; 20(2): 31-40.
  3. Назыров Ф.Г., Соколова А.С., Девятов А.В., Саяпин С.Н. Анализ состояния и перспективы развития трансформируе­мых зовдов для остановки кровотечений из варикозно-рас­ширенных вен пищевода. // Хирургия. – 2010. – №12. – С.58-64.
  4. Шерцингер А.Г., Жигалова С.Б., Мелкумов А.Б., Mанукьян В.Г. Варикозное расширение вен желудка у больных порталь­ной гипертензией: диашостика и .течение. // Анщ хирург. гепа­тологии. 2010; 15(3): 84-94.
  5. Escorsell ?, Pavel O, C?rdenas A, Morillas R, Llop E, Villanueva C, Garcia-Pag?n JC, Bosch J; Variceal Bleeding Study Group. Esophageal balloon tamponade Vs esophageal stent in controlling acute refractory variceal bleeding: A multicenter RCT. // Hepatology. 2015 Nov 24. doi: 10.
  6. Figueiredo A, Romero-Bermejo F, Perdigoto R, Marcelino P. The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care. // Critical Care Research and Practice, 2012. – vol. 2012. – ID 539412. – 13 p.
  7. Garcia-Tsao G., Lim J. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program. // American Journal of Gastroenterology, 2009. – vol. 104, N 7. – pp. 1802-1829.
  8. Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR. Covered TIPS vs endoscopic therapy?+??- blocker for prevention of variceal rebleeding. // Hepatology. 2015 Oct 30. doi: 10.1002/hep.28318.
  9. Romcea A.A., Tan?au M, Seicean A, Pascu O. The etiology of upper gastrointestinal bleeding in cirrhotic patients. // Clujul Med. 2013; 86(1):21-3.
  10. Senzolo M. M. Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. // Liver Int. 2012 Jul;32(6):919-27.
142-586-592-3-31-2020-

file

download